A5044530886- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Lung Cancer Research Studies
- Radiomics and Machine Learning in Medical Imaging
- Advanced Radiotherapy Techniques
- Cancer Genomics and Diagnostics
- Advances in Oncology and Radiotherapy
- Medical Imaging Techniques and Applications
- Toxin Mechanisms and Immunotoxins
- Neuroendocrine Tumor Research Advances
- Muscle metabolism and nutrition
- Cancer survivorship and care
- Head and Neck Cancer Studies
- Bladder and Urothelial Cancer Treatments
- Breast Cancer Treatment Studies
- Cardiovascular and exercise physiology
- Multiple and Secondary Primary Cancers
- Advanced Breast Cancer Therapies
- Music Technology and Sound Studies
- Musicology and Musical Analysis
- Hepatocellular Carcinoma Treatment and Prognosis
- Musculoskeletal Disorders and Rehabilitation
- Monoclonal and Polyclonal Antibodies Research
- Patient-Provider Communication in Healthcare
- Coffee research and impacts
University of Manchester
2023-2025
The Christie NHS Foundation Trust
2024-2025
Cancer Research UK Manchester Institute
2025
Western General Hospital
2019-2021
Edinburgh Cancer Research
2019-2021
University of South Carolina
2007
Cancer and its treatment can have significant impacts on health status, quality of life functioning patients. Direct information from patients regarding these aspects be collected via electronic platforms in the form Patient Reported Outcome Measures (ePROMs). Research has shown that use ePROMS cancer care leads to improved communication, better symptom control, prolonged survival a reduction hospital admissions emergency department attendance. Acceptability feasibility routine ePROM...
CONCORDE is a phase I platform study in NSC lung cancer testing different DNA damage response inhibitor (DDRi) RT combinations to identify the recommended II dose of DDRis. It challenging estimate toxicity rates and attribute toxicities DDRi and/or RT, due lack data on contemporary RT. We outline how we overcame challenge estimation attribution. A concurrent only calibration arm included CONCORDE. Once allocated arm, patients are randomised between RT+/-DDRi (Table 77P). An allocation ratio...
Multi-modality radiotherapy-based treatments are available to treat patients with stage III non-small cell lung cancer and associated improved clinical outcomes. However, not all benefit from these complex there is a paucity of biomarkers supporting treatment decisions tailored the individual patient. The VIGILANCE study's primary aim build prognostic model using longitudinal novel health technology data collected before, during for 1 year after completion radiotherapy in cancer. This...
The ergogenic effects of caffeine ingestion (240–840 mg) on exercise performance is well established, albeit in some cases with negative side effects. However, recent evidence shows that much smaller doses can have beneficial effect endurance as mental function. Less known about the possible synergistic low dose (CAF) and carbohydrate (CHO) feedings, especially related to team sports performance. PURPOSE: To determine (100 CAF along typically recommended CHO physical function during...
Abstract BACKGROUND Treatment pathways in metastatic breast cancer are complex. The accelerated adoption of new medicines has resulted an uncertain evidence base supporting their use. Uncertainties related to the mismatch between trial-recruited and real-world populations variation order sequential drugs. Published examples describing practice SBC scarce, mainly due complexity clinical that rely on a mixture chemotherapy, endocrine therapy biologicals, often over long period. We demonstrate...